Healthcare AI Governance

AI Governance for HealthTech and Healthcare AI Vendors

Secure Attributes helps HealthTech and healthcare AI vendors prepare governance evidence, control structures, and review-ready documentation for enterprise buyers, health systems, security teams, compliance leaders, and auditors.

Healthcare AI does not fail only because the model is wrong. It fails when no one can prove how the system handles PHI, clinical workflows, oversight, escalation, documentation, and decision risk.

Healthcare AI HealthTech Vendors PHI / HIPAA Clinical Workflows Vendor Risk Audit Evidence
Healthcare AI Readiness View REVIEW READY
PHI Risk Mapped
Clinical Use Defined
Oversight Assigned
Evidence Prepared
01 PHI, data flow, and access review
02 Clinical workflow and decision impact mapping
03 Human oversight and escalation model
04 Buyer-ready healthcare AI governance evidence
The Healthcare AI Gap

Why Healthcare AI Fails After Validation

Clinical validation creates confidence that an AI system can work. But enterprise buyers, health systems, compliance leaders, and auditors need more than performance claims.

They need to understand how the AI system behaves inside real healthcare workflows, how PHI is handled, who reviews outputs, when escalation happens, and what evidence proves the system is controlled.

A model can perform well in testing and still create risk in real clinical workflows.
Validation does not automatically prove governance, oversight, traceability, or control.
Health systems need evidence before approving AI tools that touch PHI, clinicians, patients, or care workflows.
Procurement slows when healthcare AI vendors cannot clearly explain controls, ownership, and escalation.
What Healthcare Buyers Care About

PHI, Clinical Workflows, Documentation, and Oversight

Healthcare AI governance must connect technical behavior to clinical risk, privacy obligations, operational workflows, and review-ready evidence.

PHI and Data Handling

Map how PHI, patient data, clinical notes, transcripts, prompts, outputs, logs, integrations, and third-party services are accessed, processed, stored, and protected.

Clinical Workflow Impact

Define where AI outputs enter the workflow, who relies on them, what decisions they influence, and where human review is required.

Documentation Risk

For AI scribes, summarization tools, and documentation assistants, clarify how outputs are reviewed, corrected, approved, retained, and traced.

Human Oversight

Define when clinicians, administrators, compliance teams, or other human reviewers must intervene before AI outputs affect records, decisions, or downstream workflows.

Escalation and Exceptions

Define what happens when AI outputs are uncertain, incorrect, incomplete, biased, unsafe, unsupported, or outside intended use.

Third-Party AI Risk

Map model providers, transcription services, LLM APIs, infrastructure vendors, copilots, data processors, and embedded AI dependencies.

Audit and Traceability

Organize evidence showing how AI outputs, reviews, approvals, corrections, incidents, and control decisions are documented.

Buyer Evidence

Prepare clear documentation that security, procurement, privacy, compliance, clinical leadership, and audit teams can evaluate.

Buyer and Auditor Questions

The Questions Healthcare AI Vendors Need to Answer

Health systems and enterprise healthcare buyers are asking harder questions about AI systems, especially when tools touch PHI, clinicians, documentation, patients, or regulated workflows.

What PHI Does the AI Touch?

What patient data, transcripts, documents, notes, identifiers, or clinical records are collected, processed, retained, logged, or shared?

Where Does the AI Fit Clinically?

What workflow does it support, what users rely on it, and what downstream decisions or records are affected by the output?

Who Reviews the Output?

When is human review required, who approves outputs, and how are corrections, overrides, and exceptions handled?

How Are Errors Managed?

What happens when AI outputs are incorrect, incomplete, misleading, unsafe, biased, or outside intended clinical use?

How Is the AI Monitored?

How are quality issues, drift, incidents, complaints, performance problems, and governance exceptions reviewed over time?

What Vendors Are Involved?

Which third-party AI providers, APIs, hosting services, data processors, transcription tools, and integrations support the system?

What Evidence Exists?

Can the team provide policies, data flows, control mappings, oversight models, risk registers, audit logs, and buyer-ready narratives?

Why Should We Trust It?

Can the vendor prove the AI system is governed, controlled, traceable, reviewable, and safe enough for the buyer’s environment?

Deliverables

Healthcare AI Governance Deliverables

We help prepare the practical artifacts healthcare AI vendors need for buyer review, security assessment, privacy evaluation, audit readiness, and executive confidence.

01

Healthcare AI Risk Register

Map AI use cases, PHI exposure, clinical workflow impact, ownership, risks, controls, and mitigation priorities.

02

PHI and Data Flow Summary

Document data inputs, outputs, storage, access, logging, vendors, integrations, and third-party processing paths.

03

Clinical Workflow Control Map

Define where AI outputs enter workflows, who reviews them, when approval is required, and where escalation must occur.

04

Human Oversight Model

Define review roles, approval points, escalation pathways, correction workflows, exception handling, and accountability.

05

Buyer Evidence Pack

Prepare governance, security, privacy, oversight, vendor risk, and audit evidence for health system review.

06

Healthcare AI Governance Narrative

Create a clear explanation of how the AI system is governed, monitored, controlled, reviewed, and escalated when needed.

Prepare Before Healthcare Buyers Ask

Make Healthcare AI Review-Ready Before Scrutiny Escalates

If your AI product touches PHI, clinical workflows, healthcare documentation, patient data, or decision support, we can help identify governance gaps and prepare the evidence healthcare buyers need to approve risk.

Best fit for AI medical scribes, ambient documentation tools, clinical summarization platforms, healthcare AI SaaS vendors, decision-support tools, and HealthTech companies preparing for enterprise review.